Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: Implications for tonsil cancer precursor lesions

International Journal of Cancer

Volumn 135, Issue 10, 2014, Pages 2437-2443

  Palmer, Elizabeth ^a   Newcombe, Robert G ^a   Green, Adele C ^b,c   Kelly, Carole ^d   Gill, O Noel ^d   Hall, Gillian ^e   Fiander, Alison N ^a   Pirotte, Evelyne ^a   Hibbitts, Sam J ^a   Homer, Jarrod ^b,e   Powell, Ned G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Cancer; HPV; Human papillomavirus; Oropharyngeal; Tonsil

Indexed keywords

FORMALDEHYDE; PARAFFIN; VIRUS DNA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BETA GLOBULIN GENE; CARCINOGENESIS; CHILD; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CRYPT CELL; DISEASE ASSOCIATION; DNA EXTRACTION; E6 GENE; ENZYME IMMUNOASSAY; EPITHELIUM; FEMALE; GENE; GENE AMPLIFICATION; GENE TARGETING; HEALTH STATUS; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; SEX RATIO; TONSIL; TONSIL CANCER; TONSILLAR EPITHELIA; TONSILLECTOMY; UNITED KINGDOM; VIRUS GENE; WART VIRUS; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FOLLOW UP; GENETICS; INFANT; ISOLATION AND PURIFICATION; MIDDLE AGED; NEOPLASM; NEWBORN; OROPHARYNGEAL; PALATINE TONSIL; PAPILLOMA VIRUS; PRECANCER; PRESCHOOL CHILD; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SQUAMOUS CELL CARCINOMA; TONSIL TUMOR; VIROLOGY; VIRUS INFECTION; YOUNG ADULT;

CANCER; HPV; HUMAN PAPILLOMAVIRUS; OROPHARYNGEAL; TONSIL;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; GREAT BRITAIN; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PALATINE TONSIL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; PROGNOSIS; TONSILLAR NEOPLASMS; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 84909965130     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28886     Document Type: Article

References (41)

1. D'Souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007;356: 1944-56.
2. Gillison ML, D'Souza G, Westra W, et al. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst 2008;100:407-20.
3. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 2011;29:4294-301.
4. Mehanna H, Beech T, Nicholson T, et al. Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer-systematic review and meta-analysis of trends by time and region. Head Neck 2012;35:747-55.
5. Chaturvedi AK, Engels EA, Anderson WF, et al. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 2008;26:612-19.
6. Hocking JS, Stein A, Conway EL, et al. Head and neck cancer in Australia between 1982 and 2005 show increasing incidence of potentially HPV-associated oropharyngeal cancers. Br J Cancer 2011;104:886-91.
7. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362-6.
8. Anon. Cancer Statistics Registrations, England (Series MB1), No. 41, 2010. Available at: http://www.ons.gov.uk/ons/taxonomy/index.html?nscl=Cancer+Registrations#tab-data-tables (Accessed 08/07/2013).
9. Anon. Cancer Statistics Registrations, England (Series MB1), No. 28, 1995-1997. Available at: http://www.ons.gov.uk/ons/rel/vsob1/cancer-statistics-registrations-england-series-mb1-/no-28-1995-1997/index.html (Accessed 08/07/2013).
10. Gillison ML, Broutian T, Pickard RK, et al. Prevalence of oral HPV infection in the United States, 2009-2010. JAMA 2012;307:693-703.
11. Kreimer AR, Bhatia RK, Messeguer AL, et al. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Tranm Dis 2010;37:386-91.
12. Begum S, Cao D, Gillison M, et al. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005;11:5694-9.
13. Ernster JA, Sciotto CG, O'Brien MM, et al. Prevalence of oncogenic human papillomavirus 16 and 18 in the palatine tonsils of the general adult population. Arch Otolaryngol Head Neck Surg 2009;135:554-7.
14. Chen R, Sehr P, Waterboer T, et al. Presence of DNA of human papillomavirus 16 but no other types in tumor-free tonsillar tissue. J Clin Microbiol 2005;43:1408-10.
15. Dayyani F, Etzel CJ, Liu M, et al. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010;2:15.
16. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci 2006;110:525-41.
17. Snijders PJ, Steenbergen RD, Heideman DA, et al. HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 2006;208:152-64.
18. Clewley JP, Kelly CM, Andrews N, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009;338:b1442.
19. de Roda Husman AM, Snijders PJ, Stel HV, et al. Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction. Br J Cancer 1995;72:412-17.
20. Jacobs MV, Snijders PJ, van den Brule AJ, et al. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997;35:791-5.
21. Powell NG, Boyde AM, Tristram AJ, et al. The potential impact of human papillomavirus vaccination in contemporary cytologically screened populations may be underestimated: an observational retrospective analysis of invasive cervical cancers. Int J Cancer 2009;125:2425-7.
22. Eklund C, Forslund O, Wallin KL, et al. The 2010 global proficiency study of human papillomavirus genotyping in vaccinology. J Clin Microbiol 2012;50:2289-98.
23. Collins SI, Constandinou-Williams C, Wen K, et al. Disruption of the E2 gene is a common and early event in the natural history of cervical human papillomavirus infection: a longitudinal cohort study. Cancer Res 2009;69:3828-32.
24. Kleter B, van Doorn LJ, Schrauwen L, et al. Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus. J Clin Microbiol 1999;37:2508-17.
25. van Doorn LJ, Molijn A, Kleter B, et al. Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR. J Clin Microbiol 2006;44:3292-8.
26. Tjalma WA, Fiander A, Reich O, et al. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 2013;132:854-67.
27. de Villiers EM, Fauquet C, Broker TR, et al. Classification of papillomaviruses. Virology 2004;324:17-27.
28. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-27.
29. Lancaster HO. The combination of probabilities arising from data in discrete distributions. Biometrika 1949;36:370-82.
30. Mammas IN, Sourvinos G, Michael C, et al. Human papilloma virus in hyperplastic tonsillar and adenoid tissues in children. Pediatr Infect Dis J 2006;25:1158-62.
31. Ribeiro KM, Alvez JM, Pignatari SS, et al. Detection of human papilloma virus in the tonsils of children undergoing tonsillectomy. Braz J Infect Dis 2006;10:165-8.
32. Sisk J, Schweinfurth JM, Wang XT, et al. Presence of human papillomavirus DNA in tonsillectomy specimens. Laryngoscope 2006;116:1372-4.
33. De Vuyst H, Clifford G, Li N, et al. HPV infection in Europe. Eur J Cancer 2009;45:2632-9.
34. Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011;204:566-73.
35. Kreimer AR, Johansson M, Waterboer T, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol 2013;31:2708-15.
36. Perry ME. The specialised structure of crypt epithelium in the human palatine tonsil and its functional significance. J Anat 1994;185 (Part 1):111-27.
37. Peto J, Gilham C, Fletcher O, et al. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:249-56.
38. Gillison ML, Castellsague X, Chaturvedi A, et al. Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix. Int J Cancer 2014;134:497-507.
39. Fakhry C, Rosenthal BT, Clark DP, et al. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res 2011;4:1378-84.
40. Lingen MW. Brush-based cytology screening in the tonsils and cervix: there is a difference! Cancer Prev Res (Phila) 2011;4:1350-2.
41. Herrero R, Quint W, Hildesheim A, et al. Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PloS One 2013;8:e68329.